🇺🇸
United States · US · US:0955-1020_7c9667b2-3981-4256-a6a5-0c862549f837
Docetaxel
In shortageOrange BookUNIISPLATC L01CD02
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerSanofi-Aventis U.S. LLC
CountryUS (United States)
ATC codeL01CD02
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1109551020011 VIAL, GLASS in 1 CARTON (0955-1020-01) / 1 mL in 1 VIAL, GLASS
Annotations
UNII (FDA Substance ID)
15H5577CQD
DOCETAXEL
RxCUI 72962
Orange Book
N020449
AP
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Docetaxel Injection
Raw payload (JSON)
{
"unii": {
"unii": "15H5577CQD",
"rxcui": "72962",
"inchikey": "XCDIRYDKECHIPE-QHEQPUDQSA-N",
"display_name": "DOCETAXEL",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS",
"spl_meta": {
"81686d37-a13f-46e2-b439-a84eb1433634": {
"match": "brand_token",
"title": "DOCETAXEL INJECTION [HERITAGE PHARMACEUTICALS INC. D/B/A AVET PHARMACEUTICALS INC.]",
"spl_version": "2",
"published_date": "2026-05-13"
}
},
"productid": "0955-1020_7c9667b2-3981-4256-a6a5-0c862549f837",
"productndc": "0955-1020",
"dosage_form": "INJECTION, SOLUTION, CONCENTRATE",
"orange_book": {
"appl_no": "020449",
"products": [
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**",
"product_no": "001",
"approval_date": "May 14, 1996"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "20MG/ML (20MG/ML)",
"product_no": "003",
"approval_date": "Aug 3, 2010"
},
{
"rs": false,
"rld": true,
"te_code": null,
"strength": "80MG/4ML (20MG/ML)",
"product_no": "004",
"approval_date": "Aug 2, 2010"
},
{
"rs": false,
"rld": true,
"te_code": "AP",
"strength": "160MG/8ML (20MG/ML)",
"product_no": "005",
"approval_date": "Apr 13, 2012"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "DOCETAXEL",
"shortage_reason": "Docetaxel Injection",
"shortage_status": "current",
"proprietary_name": "Docetaxel",
"active_ingred_unit": "mg/mL",
"application_number": "NDA020449",
"marketing_category": "NDA AUTHORIZED GENERIC",
"nonproprietary_name": "Docetaxel",
"start_marketing_date": "20101021",
"active_numerator_strength": "20"
}Related drugs
Other records sharing ATC code L01CD02.
- BEBaglycacon 10 mg/mlSandoz
- BEBaglycacon 10 mg/mlSandoz
- BEBaglycacon 10 mg/mlSandoz
- 🇺🇸BEIZRAYZydus Pharmaceuticals USA Inc.
- 🇺🇸BEIZRAYZydus Pharmaceuticals USA Inc.
- 🇺🇸BEIZRAYZhuhai Beihai Biotech Co., Ltd.
- 🇺🇸BEIZRAYZhuhai Beihai Biotech Co., Ltd.
- NLDemotaxel Mono 20 mg/ml, concentraat voor oplossing voor infusieDemo S.A. Pharmaceutical Industry
Access this data programmatically
Query Docetaxel and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.